More articles about: Cardiovascular: Diseases & Conditions
Health Lab
Longtime Michigan football announcer makes call on heart health
A famous sports announcer for University of Michigan football finds himself getting heart care at Michigan Medicine and spreading the word to others to be proactive about their heart health.
Health Lab
Higher costs limit attendance for life changing cardiac rehab
Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a University of Michigan study suggests.
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
Health Lab
Roy’s Michigan Answer: Second opinion saves patient’s heart
Michigan Medicine's team of cardiology experts offered an advanced, minimally invasive coronary intervention, which restored one patient back to good health
Health Lab
Recycled pacemakers function as well as new devices, international study suggests
Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and middle-income countries, where many patients cannot afford the treatment.
Health Lab
Planting a tree, and hope, for a heart healthy future
A complex mitral valve repair by Michigan Medicine cardiac specialists helps restore health and happiness to one Michigan patient and his family.
Health Lab
Women more likely than men to die after heart surgery complications
Despite having no greater chance of developing problems after high risk cardiovascular surgery, women are more likely than men to die from post-operative complications, a University of Michigan-led study suggests.
Health Lab
Timely CPR saves runner who collapsed during first week of college
Bystander CPR saves a first year college student who collapsed from sudden cardiac arrest while running during his first week of school.
Health Lab
From babies needing heart surgeries to Michigan Wolverines
After long congenital heart journeys at University of Michigan Health C.S. Mott Children’s Hospital and U-M Health West, three 2024 Grand Rapids area high school graduates are back at University of Michigan: this time, as official Michigan Wolverines.
Health Lab
Motivational speaker reunites with Survival Flight nurses after sudden aortic dissection
A father and motivational speaker, who experienced an urgent heart problem, reunites with his Survival Flight nurses who helped save his life
Health Lab
The heart of the question: Who can get Medicare-covered weight loss medicine?
Wegovy (semaglutide) now has Medicare approval for coverage among people with obesity and cardiovascular disease but no diabetes; a study looks at what level of risk might make someone eligible.
Health Lab
How common is pacemaker use after heart valve surgery?
People having heart surgery to repair leaking mitral or tricuspid valves may receive a pacemaker more often than necessary — leading to a greater risk for life threatening complications.
Health Lab
Risk of clots, stroke from incorrect blood thinner dosing reduced using online dashboard
Doctors and pharmacists treating people with blood thinners can now reduce the rate of inappropriate dosing — as well as blood clots and strokes that can result from it — using an electronic patient management system.
Health Lab
Black stroke patients arrive later to hospitals, EMS less likely to notify
Research found that it took approximately 28 minutes longer for a Black patient to be brought in for emergency care after displaying symptoms of a stroke.
Health Lab
Most blood thinner dosing problems happen after initial prescription
More than two-thirds of those people take a type of blood thinner called a direct oral anticoagulant. These DOACs, such as rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), are under- or over-prescribed in up to one in eight patents. These prescribing issues can have life-threatening consequences, and they most often occur after a provider writes the initial prescription, according to a study led by Michigan Medicine.
